Discordant P-glycoprotein antigen expression and transport function in acute myeloid leukemia

Leukemia

Volumn 9, Issue 11, 1995, Pages 1882-1887

  Xie, X Y ^a   Robb, D ^b   Chow, S ^a   Hedley, D W ^a  

^a Prncs Margaret Hospital Ontario C   (Canada)

^b MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

Author keywords

Drug resistance; Flow cytometry; MRK 16; Neuraminidase; P glycoprotein

Indexed keywords

CYCLOSPORIN A; DAUNORUBICIN; GLYCOPROTEIN P; SIALIDASE;

ACUTE GRANULOCYTIC LEUKEMIA; ANTIGEN EXPRESSION; ARTICLE; CALIBRATION; CELL LINE; CHRONIC LYMPHATIC LEUKEMIA; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG ACCUMULATION; FLOW CYTOMETRY; GLYCOSYLATION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN TRANSPORT;

EID: 0028808328     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Bradley G, Juranka PF, Ling V. Mechanisms of multidrug resistance. Biochim Biophys Acta 1988; 948: 87-128.
2. Gottesman MM, Pastan I. Minireview: the multidrug transporter, a double-edged sword. J Biol Chem 1988; 263: 12163-12166.
3. Georges E, Sharom FJ, Ling V. Multidrug resistance and chemosensitization: therapeutic implications for cancer chemotherapy. Adv Pharmacol 1993; 21: 185-220.
4. Arao S et al. Expression of multidrug resistance gene and localization of P-glycoprotein in human primary ovarian cancer. Cancer Res 1994; 54: 1355-1359.
5. Rodriguez C, Commes T, Robert J, Rossi JF. Expression of P-glycoprotein and anionic glutathione S-transferase genes in non-Hodgkin's lymphoma. Leukemia Res 1993; 17: 149-156.
6. Chan HS et al. P-glycoprotein expression as a predictor of the out-come of therapy for neuroblastoma. New Engl J Med 1991; 325: 1608-1614.
7. Holmes JA, West RR. The effect of MDR-1 gene expression on outcome in acute myeloid leukaemia. Br J Cancer 1994; 69: 382-384.
8. Ino T et al. Expression of p-glycoprotein in de novo acute myelogenous leukemia at initial diagnosis: results of molecular and functional assays, and correlation with treatment outcome. Leukemia 1994; 8: 1492-1497.
9. Maslak P, Hegewish-Becker S, Godfrey L, Andreef M. Flow cytometric determination of the multidrug-resistant phenotype in acute leukemia. Cytometry 1994; 17: 84-93.
10. Zöchbauer S et al. P-glycoprotein expression as unfavorable prognostic factor in acute myeloid leukemia. Leukemia 1994; 8: 974-977.
11. Goasguen JE et al. Expression of the multidrug resistance-associated P-glycoprotein (P-170) in 59 cases of de novo acute lymphoblastic leukemia: prognostic implications. Blood 1993; 81: 2394-2398.
12. Marie J-P, Faussat-Suberville A-M, Zhou D, Zittoun R. Daunorubicin uptake by leukemic cells. Correlations with treatment out-come and mdr1 expression. Leukemia 1993; 7: 825-831.
13. Campos L et al. Clinical significance of multidrug resistance P-glycoprotein expression on acute nonlymphoblastic leukemia cells at diagnosis. Blood 1992; 79: 473-476.
14. Cole SPC et al. Overexpression of a transporter gene in a multi-drug-resistant human lung cancer cell line. Science 1992; 258: 1650-1654.
15. Grant CE et al. Overexpression of multidrug resistance-associated protein (MRP) increases resistance to natural product drugs. Cancer Res 1994; 54: 357-361.
16. Burger H et al. Expression of the multidrug resistance-associated protein (MRP) in acute and chronic leukemias. Leukemia 1994; 8: 990-997.
17. Abbaszadegan MR et al. Analysis of multidrug resistance-associated protein (MRP) messenger RNA in normal and malignant hematopoietic cells. Cancer Res 1994; 54: 4676-4679.
18. Miwa H et al. Expression of MDR1 gene in acute leukemia cells: association with CD7+ acute myeloblastic leukemia/acute lymphoblastic leukemia. Blood 1993; 82: 3445-3451.
19. Sonneveld P et al. High expression of the multidrug resistance p-glycoprotein in high risk myelodysplasia is associated with immature phenotype. Leukemia 1993; 7: 963-969.
20. Haber DA. Multidrug resistance (mdr1) in leukemia: is it time to test? Blood 1992; 79: 295-298.
21. Maruyama Y, Murohashi I, Nara N, Aoki N. Effects of verapamil on the cellular accumulation of daunorubicin in blast cells and on the chemosensitivity of leukaemic blast progenitors in acute myelogenous leukaemia. Br J Haematol 1989; 72: 357-362.
22. Kartner N, Evernden-Porelle D, Bradley G, Ling V. Detection of p-glycoprotein in multidrug-resistant cell lines by monoclonal antibodies. Nature 1985; 316: 820-823.
23. Cumber PM et al. Expression of the multiple drug resistance gene (mdr-1) and epitope masking in chronic lymphatic leukaemia. Br J Haematol 1990; 76: 226-230.
24. Cumber PM et al. Increased drug accumulation ex vivo with cydosporin in chronic lymphatic leukemia and its relationship to epitope masking of P-glycoprotein. Leukemia 1991; 5: 1050-1053.
25. Deffie AM et al. Multifactorial resistance to Adriamycin: relationship of DNA repair, glutathione transferase activity, drug efflux, and P-glycoprotein in cloned cell lines of Adriamycin-sensitive and -resistant P388 leukemia. Cancer Res 1988; 48: 3595-3602.
26. Herweijer H, Sonneveld P, Baas F, Nooter K. Expression of mdr1 and mdr3 multidrug-resistance genes in human acute and chronic leukemias and association with stimulation of drug accumulation by cyclosporine. J Natl Cancer Inst 1990; 82: 1133-1140.